Pharma Marketletter

Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.

HIV vaccine trials begin in Japan.(Brief Article)
January 26, 2004

Amgen and Genome end bone disease accord.(Brief Article)
January 26, 2004

Genentech sees 30% rise in EPS, fuelled by 28% surge in revenues for 2...
January 26, 2004

Drug discovery spending declines in face of changing dynamics.(Brief A...
January 26, 2004

US health, safety and drug access: FDA views 2003's actions and its pl...
January 26, 2004

Nizhfarms 2003 profits leap 58%.(Brief Article)
January 26, 2004

Options for a P&G/Aventis link-up reviewed by broker Natexis.
January 26, 2004

Popularity of OTC allergy products puts pressure on US Rx prices.(Brie...
January 26, 2004

Sepracor completes $150M notes sale.(Brief Article)
January 26, 2004

Dr Reddy's organizes India's biggest pharma symposium.(Dr. Reddy's Lab...
January 26, 2004

Edwards Lifesciences concludes arbitration with Baxter.(Brief Article)
January 26, 2004

Eon Labs starts shipping bupropion.(Brief Article)
January 26, 2004

Metabasis and Merck & Co sign HCV accord.(Brief Article)
January 26, 2004

AtheroGenics enters deal with Fujisawa.(Brief Article)
January 26, 2004

Neurogen's drug fails in Ph II asthma trial.(NGD 2000-1)(Brief Article...
January 26, 2004

New use for Aventis' Taxotere in Japan.(Brief Article)
January 26, 2004

Positive new data for Jerini's icatibant.(Brief Article)
January 26, 2004

Euro Commission seeks to clarify EU rules on pharma parallel imports.
January 26, 2004

After two failed attempts, Spain's Probitas eyes stock listing in summ...
January 26, 2004

Fresenius to expand biotech activities.(Brief Article)
January 26, 2004

Roche to set up R&D center in China.(Brief Article)
January 26, 2004

Richter ups stake in GZF Polfa.(Brief Article)
January 26, 2004

Ex-Shire CEO arises with Chesyl Pharma.(Rolf Stahel)(Brief Article)
January 26, 2004

ASDA UK ends VAT on cough/cold OTCs.
January 26, 2004

Generics "can be dearer in Canada than USA".(Brief Article)
January 26, 2004

US FDA approvals of innovative drugs up in 2003, with lower review tim...
January 26, 2004

FemmePharma's FP1096 shows promise.(Women health care)(Brief Article)
January 26, 2004

Corixa and GSK to start trial for TB vaccine.(Brief Article)
January 26, 2004

Aventis' Taxotere-based regimen improves survival rates in NSCLC patie...
January 26, 2004

UPDATE: Lilly's Zyprexa gets OK from FDA for new use.(Brief Article)
January 26, 2004

Innogenetics' initial 2004 outlook positive.(Brief Article)
January 26, 2004

Pfizer to sell allergy diagnostics business for $575M.(Brief Article)
January 26, 2004

Forest profit boosted by antidepressants.(Brief Article)
January 26, 2004

Medarex and Xerion enter antibody deal.(Brief Article)
January 26, 2004

Tokyo pharma stocks - week to Jan 19.
January 26, 2004

SPECTRUM.(Illustration)
January 26, 2004

Stock Commentary - New York.(Brief Article)
January 26, 2004

Stock Commentary - Europe.
January 26, 2004

CV Therapeutics' Ranexa reduces angina severity; CARISA trial findings...
January 26, 2004

Enbrel cleared for new use in EU.(Brief Article)
January 26, 2004

Health Minister warns German funds, doctors.(Brief Article)
January 26, 2004

Spain: decentralized policymaking urged.
January 26, 2004

Bush warns Congress of Rx benefit "veto".
January 26, 2004

US consumers back govt action on Rx costs.
January 26, 2004

US Congress moves on fake drugs, diversion.(United States, House Energ...
January 26, 2004

S-P launches Rebetol oral solution in USA.(Brief Article)
January 26, 2004

Shareholders approve Angiotech stock split, option plans.(Angiotech Ph...
January 26, 2004

Affymetrix repurchases notes.(Brief Article)
January 26, 2004

Sontra gets $1.5M payment from Bayer Diagnostics.(Brief Article)
January 26, 2004

PhRMA chief to retire.(Alan Holmer of Pharmaceutical and Research Manu...
January 26, 2004

Dendrite buys Uto Brain of Japan.(Brief Article)
January 26, 2004

Servier extends research deal with Cortex.(Brief Article)
January 26, 2004

Shionogi R&D update.(Brief Article)
January 26, 2004

Sumitomo and AstraZeneca sign deal.(Brief Article)
January 26, 2004

Enzon and Inex sign accord for Onco TCS.(Brief Article)
January 26, 2004

Myriad Genetics' MPC-6827 shows promise as anticancer agent.
January 26, 2004

Schering AG and Organon to test "male pill".(Brief Article)
January 26, 2004

Amsterdam Molecular names Sander van Deverter as CSO.(Brief Article)
January 26, 2004

EuropaBio names new secretary general.(Johan Vanhemelrijck, Hugo Schep...
January 26, 2004

Appointments at Neurochem.(Christine Lennon, Judith Paquin)(Brief Arti...
January 26, 2004

Hans Fliri named general manager of Scynexis Europe.(Brief Article)
January 26, 2004

Avigen names Dawn McGuire chief medical officer.(Brief Article)
January 26, 2004

$2M milestone for Cortex from Organon.(Brief Article)
January 26, 2004

Senior appointments at Genentech.(Hal Barron, Varun Nanda, Patrick Yan...
January 26, 2004

Positive new data for Vicuron's dalbavancin.
January 26, 2004

ImmunoGen to conduct own studies.
January 26, 2004

Schering AG's Zevalin cleared by EC.
January 26, 2004

Sanofi-Synthelabo's 2003 sales up 15.6%.(Brief Article)
January 26, 2004

Late news: Novartis.(Brief Article)
January 26, 2004

GE takeover of Amersham gets EU OK.(Brief Article)
January 26, 2004

Roche denies interest in merger with Novartis.(Brief Article)
January 26, 2004

Sepracor's 4th-qtr Xopenex revenues leap 53%.(Brief Article)
January 26, 2004

French govt OKs reimbursement of HPV testing for cervical cancer.
January 26, 2004

Abbott buy of i-STAT clears hurdle.(Brief Article)
January 26, 2004

Pfizer considering options for non-core consumer health ops.(Brief Art...
January 26, 2004

Page 1|2|3|4|5|6